Fresenius Medical Care Singapore is a health care startup established in 1997, and has grown to become the world's largest integrated provider of products and services for individuals undergoing dialysis. The company operates in over 120 countries, with 3000 dialysis clinics and 40 production sites worldwide, offering a complete solution for people with chronic kidney failure.
Fresenius Medical Care Singapore plays a key role in this global network, serving as the largest private provider of dialysis care in the country and operating more than 20 dialysis centres island-wide. The company distributes a complete range of haemodialysis (HD) machines, peritoneal dialysis (PD) systems, water treatment systems, treatment recliners, dialysis consumables, and other related products. Additionally, their highly experienced and competent nurses perform dialysis treatment in the acute setting at prominent hospitals such as Mt Elizabeth, Parkway East, and Gleneagles Hospitals in Singapore.
The company received a Private Equity Round investment from 3i Group on 01 January 2000. This investment has further fueled the company's mission to provide integrated services, develop new solutions for renal care, and expand its global footprint in the health care industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
01 Jan 2000 |
| Venture Round | Unknown | 1 |
|
05 Jun 1997 |
No recent news or press coverage available for Fresenius Medical Care Singapore.
We care about your data, and we'd love to use cookies make your experience better.
